Background: Botulinum toxin type A (BoNTA) is commonly injected to treat facial wrinkles. Complications include pain, erythema, bruising, and potential infection. RT001 Botulinum Toxin Type A Topical Gel (RT001) is under development for the treatment of lateral canthal lines (LCLs).
Objective: To assess the efficacy and safety of RT001 for the treatment of LCLs using a randomized, double-blind, repeat-dose, placebo-controlled study design.
Methods & Materials: Healthy adult subjects were randomized to receive RT001 (N=19) or placebo (N=17) applied to their lateral canthal areas (LCAs). To evaluate safety of repeat exposure, treatment was administered at baseline and week 4. The primary efficacy measure was improvement in baseline LCL severity using the Investigator's Global Assessment of Lateral Canthal Line at Rest (IGA-LCL) Severity Scale.
Results: At 8 weeks, 19 (50%) LCAs treated with RT001 showed a 2-point or greater improvement in baseline IGA-LCL severity, versus none (0%) of the placebo-treated subjects (p<.001); 36 (94.7%) LCAs treated with RT001 showed a 1-point or more improvement in baseline IGA-LCL severity, versus five (14.7%) placebo-treated LCAs (p<.001). There were no treatment-related adverse events.
Conclusion: RT001 was well tolerated and demonstrated an improvement in LCLs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1524-4725.2010.01711.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Novel Surgical Technique Involving Bone Fixation Canthoplasty, Middle Lamellar Recession and Mucograft Spacer in Treating Patients with Euryblepharon.
Ophthalmic Plast Reconstr Surg
December 2024
Adnexal Department, Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Purpose: Euryblepharon is a rare congenital eyelid malformation characterized by symmetrical horizontal enlargement of the palpebral fissure. The eyelid is shortened vertically compared with the horizontal dimension. The lateral canthus is most commonly affected.
View Article and Find Full Text PDFOrbital Septum Posterior to Medial Canthal Tendon Area.
Ophthalmic Plast Reconstr Surg
December 2024
Department of Oculoplastic, Orbital and Lacrimal Surgery, Aichi Medical University Hospital.
Purpose: To examine the anatomy of the orbital septum posterior to the medial canthal tendon area.
Materials And Methods: We performed 3 anatomical dissections in the present study. The first one was a microscopic study in which exenterated specimens from 6 Japanese cadavers (age from 77 to 93 years at death) were cut inferno-horizontally, including the Müller muscle, medial rectus pulley, and lateral rectus pulley, and stained with Masson's trichrome.
Observations on the Etiology of Involutional Entropion.
Ophthalmic Plast Reconstr Surg
December 2024
John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, U.S.A.
Purpose: To review evidence supporting proposed anatomic etiologies of involutional entropion and propose additional potential contributing factors.
Methods: A literature review was performed to identify publications describing possible etiologies of involutional entropion. The author's clinical observations and information supporting new proposed causes are presented.
Orbital Intraosseous Abscess After Lateral Bony Orbital Decompression.
Ophthalmic Plast Reconstr Surg
December 2024
Oculoplastic and Orbital Surgery Service, Wills Eye Hospital, Philadelphia, Pennsylvania.
A 66-year-old woman status post bony lateral orbital decompression for thyroid eye disease presented with recurrent episodes of left lateral canthal edema and erythema, despite repeated courses of oral antibiotics, titanium hardware removal, and repeated exploratory orbitotomies with debridement and curettage. MRI later revealed an intraosseous fluid collection in the left greater sphenoid wing. Another exploratory orbitotomy was performed and an intraosseous abscess was identified.
View Article and Find Full Text PDFEfficacy and Safety of RelabotulinumtoxinA Liquid Botulinum Toxin in the Treatment of Lateral Canthal Lines: Results From the Phase 3 READY-2 Study.
Dermatol Surg
December 2024
Galderma, Dallas, Texas.
Background: RelabotulinumtoxinA (RelaBoNT-A) is a complex-free, ready-to-use, liquid botulinum toxin A.
Objective: Efficacy/safety of RelaBoNT-A treatment for lateral canthal lines (LCL).
Methods: Randomized adults received RelaBoNT-A (30 U/side; n = 230) or placebo (n = 73) during a 6-month, double-blind, Ph3 study (Relabotulinumtoxin Aesthetic Development Study-2 [READY-2]).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!